SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-025593
Filing Date
2021-06-23
Accepted
2021-06-23 20:35:39
Documents
2
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2865
2 EX-24 DOCUMENT attachment1.htm EX-24 4657
  Complete submission text file 0000899243-21-025593.txt   8932
Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Wallace Owen B. (Reporting) CIK: 0001778843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40522 | Film No.: 211040245

Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)